Company

Zymeworks Inc.

Headquarters: Vancouver, BC, Canada

Founded: 2003

Employees: 455

CEO: Mr. Kenneth H. Galbraith C.A.

NYSE: ZYME -1.49%

Market Cap

$627.9 Million

USD as of July 1, 2024

Market Cap History

Zymeworks Inc. market capitalization over time

Evolution of Zymeworks Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Zymeworks Inc.

Detailed Description

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; BeiGene, Ltd.; and Exelixis, Inc. It also has licensing and research collaboration with LEO Pharma A/S to research, develop, and commercialize bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was incorporated in 2003 and is headquartered in Vancouver, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Zymeworks Inc. has the following listings and related stock indices.


Stock: NYSE: ZYME wb_incandescent

Stock: FSX: 0OX wb_incandescent

Product & Services

Pharmaceuticals

Key People

Ali Tehrani Donald L. Drakeman

Details

Headquarters:

1385 West 8th Avenue

Suite 540

Vancouver, BC V6H 3V9

Canada

Phone: 604 678 1388

Fax: 604 737 7077